Juliette Audet

Juliette Audet

Chief Strategy and Business OfficeratNewAmsterdam Pharma Co· In proxies 2023–2024

Pay in FY2024NewAmsterdam Pharma Co stock +130.1% the same year

Juliette Audet was paid $3.1M in FY2024 (Dec). NewAmsterdam Pharma Co stock rose 130.1% that year.

Pay$100 in the stock at the end of FY23 → $230
Pay is from the Summary Compensation Table of each NewAmsterdam Pharma Co proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NewAmsterdam Pharma CoPublic company · 3 yr
    • Chief Strategy and Business Officer2023 – Present · 3 yrStock in role +83%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?